Page last updated: 2024-10-23

betahistine and Brain Damage, Chronic

betahistine has been researched along with Brain Damage, Chronic in 1 studies

Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hood, NA1

Other Studies

1 other study available for betahistine and Brain Damage, Chronic

ArticleYear
Diseases of the central nervous system. Cerebral atherosclerosis, transient ischaemic attacks, Menière's disease, and disorders of balance.
    British medical journal, 1975, Nov-15, Volume: 4, Issue:5993

    Topics: Accident Proneness; Anticoagulants; Betahistine; Brain Damage, Chronic; Cerebrovascular Circulation;

1975